BiotechTube
Home/FerroptoCure/Hideyuki Saya
HS

Hideyuki Saya

Director, M.D., Ph.D.

FerroptoCure

Therapeutic Areas

Oncology

FerroptoCure Pipeline

DrugIndicationPhase
FC001Cancer (unspecified)Phase 1
FC004Cancer (unspecified)Preclinical

Leadership Team at FerroptoCure

YO
Yuji Otsuki
CEO, M.D., Ph.D.
ON
Osamu Nagano
Director, DDS., Ph.D.
TN
Toru Natsume
Director, Ph.D. (CSO at RBI)
NN
Nobuhiro Nishiyama
Director, Ph.D.
View full FerroptoCure profile